Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients.

RATIONALE Current clinical prediction scores for acute lung injury (ALI) have limited positive predictive value. No studies have evaluated predictive plasma biomarkers in a broad population of critically ill patients or as an adjunct to clinical prediction scores. OBJECTIVES To determine whether plasma angiopoietin-2 (Ang-2), von Willebrand factor (vWF), interleukin-8 (IL-8), and/or receptor for advanced glycation end products (sRAGE) predict ALI in critically ill patients. METHODS Plasma samples were drawn from critically ill patients (n = 230) identified in the emergency department. Patients who had ALI at baseline or in the subsequent 6 hours were excluded, and the remaining patients were followed for development of ALI. MEASUREMENTS AND MAIN RESULTS Nineteen patients developed ALI at least 6 hours after the sample draw. Higher levels of Ang-2 and IL-8 were significantly associated with increased development of ALI (P = 0.0008, 0.004, respectively). The association between Ang-2 and subsequent development of ALI was robust to adjustment for sepsis and vasopressor use. Ang-2 and the Lung Injury Prediction Score each independently discriminated well between those who developed ALI and those who did not (area under the receiver operating characteristic curve, 0.74 for each), and using the two together improved the area under the curve to 0.84 (vs. 0.74, P = 0.05). In contrast, plasma levels of sRAGE and vWF were not predictive of ALI. CONCLUSIONS Plasma biomarkers such as Ang-2 can improve clinical prediction scores and identify patients at high risk for ALI. In addition, the early rise of Ang-2 emphasizes the importance of endothelial injury in the early pathogenesis of ALI.

[1]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[2]  B. Thompson,et al.  Plasma angiopoietin-2 in clinical acute lung injury: Prognostic and pathogenetic significance* , 2012, Critical care medicine.

[3]  Q. Shu,et al.  Plasma sRAGE enables prediction of acute lung injury after cardiac surgery in children , 2012, Critical Care.

[4]  M. Matthay,et al.  Plasma Levels Of The Receptor For Advanced Glycation End Products (RAGE) Are Elevated In Early Acute Lung Injury But Not In Severe Sepsis , 2012, ATS 2012.

[5]  Lung,et al.  Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury. , 2011, American journal of respiratory and critical care medicine.

[6]  J. Zijlstra,et al.  Acute administration of recombinant Angiopoietin-1 ameliorates multiple-organ dysfunction syndrome and improves survival in murine sepsis. , 2011, Cytokine.

[7]  L. Ware,et al.  Biomarkers in acute lung injury--marking forward progress. , 2011, Critical care clinics.

[8]  Ognjen Gajic,et al.  Derivation and Diagnostic Accuracy of the Surgical Lung Injury Prediction Model , 2011, Anesthesiology.

[9]  H. Hakonarson,et al.  ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. , 2011, American journal of respiratory and critical care medicine.

[10]  P. Parsons,et al.  Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury , 2011, Critical care medicine.

[11]  Alison Fox-Robichaud,et al.  Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis* , 2011, Critical care medicine.

[12]  Ognjen Gajic,et al.  Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. , 2011, American journal of respiratory and critical care medicine.

[13]  M. Matthay,et al.  Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients , 2010, Critical care medicine.

[14]  V. Herasevich,et al.  Acute lung injury prediction score: derivation and validation in a population-based sample , 2010, European Respiratory Journal.

[15]  D. Needham,et al.  Beyond mortality: future clinical research in acute lung injury. , 2010, American journal of respiratory and critical care medicine.

[16]  Lesly A. Dossett,et al.  Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis. , 2010, The Journal of trauma.

[17]  G. Bernard,et al.  Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. , 2010, Chest.

[18]  S. Karumanchi,et al.  Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium , 2009, Molecular and Cellular Biology.

[19]  R. Balk Positive End-Expiratory Pressure Setting in Adults With Acute Lung Injury and Acute Respiratory Distress Syndrome: A Randomized Controlled Trial , 2009 .

[20]  P. Parsons,et al.  Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury , 2008, Thorax.

[21]  V. V. van Hinsbergh,et al.  Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients , 2008, Thorax.

[22]  M. Matthay,et al.  Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury , 2008, Critical care.

[23]  Arthur S Slutsky,et al.  Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. , 2008, JAMA.

[24]  S. Jaber,et al.  Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. , 2008, JAMA.

[25]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[26]  D. Talmor,et al.  CIRCULATING ANGIOPOIETIN 2 CORRELATES WITH MORTALITY IN A SURGICAL POPULATION WITH ACUTE LUNG INJURY/ADULT RESPIRATORY DISTRESS SYNDROME , 2007, Shock.

[27]  A. Arroliga,et al.  Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[28]  R. Homer,et al.  Hyperoxia causes angiopoietin 2–mediated acute lung injury and necrotic cell death , 2006, Nature Medicine.

[29]  Gordon R Bernard,et al.  Comparison of two fluid-management strategies in acute lung injury. , 2006, The New England journal of medicine.

[30]  M. Matthay,et al.  Biological markers of lung injury before and after the institution of positive pressure ventilation in patients with acute lung injury , 2006, Critical care.

[31]  M. Matthay,et al.  Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. , 2006, American journal of respiratory and critical care medicine.

[32]  D. Christiani,et al.  Excess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in Humans , 2006, PLoS medicine.

[33]  G. Bernard,et al.  Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury* , 2005, Critical care medicine.

[34]  Marek Ancukiewicz,et al.  Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. , 2009, The New England journal of medicine.

[35]  P. Parsons,et al.  Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. , 2004, American journal of respiratory and critical care medicine.

[36]  M. Matthay,et al.  von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury , 2001, Critical care medicine.

[37]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[38]  Peggo K. W. Lam,et al.  Derivation of a prediction rule for post-traumatic acute lung injury. , 1999, Resuscitation.

[39]  P. Parsons,et al.  Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome. , 1996, Critical care medicine.

[40]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[41]  Peter Harrison,et al.  Platelet a-granules , 1993 .

[42]  Paul J. Harrison,et al.  Platelet alpha-granules. , 1993, Blood reviews.

[43]  D. Green,et al.  Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. , 1990, The Journal of clinical investigation.